Cleave Biosciences
Burlingame, US · Delaware corporation · 8 known investors
Founders & leadership
MR
Mark RolfeExecutive
LS
Laura ShawverExecutive
TS
Timothy SmithExecutive
Board
AS
PT
Peter ThompsonBoard director
CG
Carol GallagherBoard director
JR
Jonathan RootBoard director
AS
Andrew SchwabBoard director
DH
Dennis HennerBoard director
LS
Lewis ShusterBoard director
Investors · 8
Astellas Venture Management LLCSouth San Francisco · $200K – $5M
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
Nextech InvestZurich · $648K – $3.2Mvia Alfred Scheidegger · board
5AM VenturesreportedBoston · $100K – $4M
Clarus VenturesreportedMenlo Park
OrbiMedreportedNew York · $1M – $75M
Osage University PartnersreportedBala Cynwyd
US Venture PartnersreportedMenlo Park · $500K – $10M
Reported raises · per SEC filings
Form D private placements$37.9M disclosed across 2 of 3 rounds · 2016–2025
▶$12MraisedJun 2019 · 11 investors · BiotechnologyRule 506(b)
▶$12MraisedJun 2019 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amy BurroughsExecutive Officer, Director
- Laura ShawverDirector
- Jonathan RootDirector
- Andrew SchwabDirector
- Peter ThompsonDirector
- Offering amount
- $20.8M
- Amount sold
- $12M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$26MraisedAug 2016 · 13 investors · BiotechnologyRule 506(b)
▶$26MraisedAug 2016 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alfred ScheideggerDirector
- Mark RolfeExecutive Officer
- Peter ThompsonDirector
- Laura ShawverExecutive Officer, Director
- Lewis ShusterDirector
- Carol GallagherDirector
- Jonathan RootDirector
- Timothy SmithExecutive Officer
- Andrew SchwabDirector
- Dennis HennerDirector
- Offering amount
- $36.8M
- Amount sold
- $26M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Cleave Biosciences's investors?
- Cleave Biosciences's investors include Astellas Venture Management LLC, New Enterprise Associates (NEA), Nextech Invest, 5AM Ventures, Clarus Ventures, OrbiMed, Osage University Partners, US Venture Partners.
- How much funding has Cleave Biosciences raised?
- Cleave Biosciences has disclosed $37.9M raised across 2 of its 3 known rounds.
- Where is Cleave Biosciences headquartered?
- Cleave Biosciences is headquartered in Burlingame, US.